Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06354192 · ClinicalTrials.gov registry record
Precision Nudging for Hypertension Management: Observational Study
A clinical trial of Hypertension, sponsored by Lirio.
- Recruiting
- Registry status
- 12,000
- Enrollment target
- 1
- Study location
NCT06354192: Recruiting study of Hypertension, sponsored by Lirio.
NCT06354192 is a study of Hypertension that is actively recruiting participants, run by Lirio. The registered enrollment target is 12,000 participants, above the 3,482-participant average among 470 other Hypertension trials with a reported enrollment target (245% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06354192, a study of Hypertension, is actively recruiting participants, sponsored by Lirio.
- RECRUITING
- Registry status
- 12,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the proposed observational study is to explore the relations between data-driven personalization and equitable health outcomes in a digital health intervention (DHI) for hypertension management. In the current intervention, behavioral reinforcement learning is applied to personalize intervention content to maximize the behavioral outcomes of three target behaviors critical for effective hypertension management: clinical encounters, medication adherence, and self-monitoring of blood pressure (SMBP).
Primary Outcome
Adherence with recommended clinical encounters given eligibility based on blood pressure readings and medication
Conditions Studied
Interventions
- BEHAVIORAL Precision Nudging for Hypertension Management
Study Locations (1)
North Carolina
- Cone Health clinics - Greensboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,000 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2026-11-01 |
What NCT06354192 shows while recruiting
NCT06354192 is an observational study that tracks outcomes without assigning an intervention. Its 12,000 participants enrollment target places it among the larger protocols in the corpus, above the 3,482-participant average among 470 other Hypertension trials with a reported enrollment target (245% higher).
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Precision Nudging for Hypertension Management is the first listed.
NCT06354192 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06354192 about?
NCT06354192 is a clinical study titled "Precision Nudging for Hypertension Management: Observational Study". The purpose of the proposed observational study is to explore the relations between data-driven personalization and equitable health outcomes in a digital health intervention (DHI) for hypertension management. In the current intervention, behavioral reinforcement learning is applied to personalize i...
What is the current status of trial NCT06354192?
This trial is currently recruiting. The enrollment target is 12,000 participants. The study started on 2024-05-01. Estimated completion is 2026-11-01.
What conditions does trial NCT06354192 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT06354192?
The interventions under investigation include: Precision Nudging for Hypertension Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT06354192?
This trial is sponsored by Lirio, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06354192 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06354192's enrollment target sits among peer trials
12,000 17th of 470 higher than 454 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Childhood-Onset Essential Hypertension Natural History Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- NCT04937868 · 12,000 participants
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
- NCT06059963 · 12,000 participants
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
- NCT06273618 · 12,000 participants · NA
iLookOut Micro-learning to Improve Knowledge Retention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI